Interferon-beta and neuroprotection in multiple sclerosis--facts, hopes and phantasies

Exp Neurol. 2007 Jan;203(1):1-4. doi: 10.1016/j.expneurol.2006.09.007. Epub 2006 Oct 25.

Authors

Bernd C Kieseier¹, Hans-Peter Hartung

Affiliation

¹ Department of Neurology, Heinrich-Heine-University Moorenstrasse 5, 40225 Düsseldorf, Germany.

PMID: 17069803
DOI: 10.1016/j.expneurol.2006.09.007

No abstract available

Publication types

Review
Comment

MeSH terms

Animals
Atrophy / drug therapy
Atrophy / immunology
Atrophy / physiopathology
Brain / drug effects
Brain / immunology
Brain / pathology
Disease Models, Animal
Humans
Immunologic Factors / pharmacology*
Immunologic Factors / therapeutic use
Immunosuppression Therapy / methods
Immunosuppression Therapy / trends
Interferon-beta / pharmacology*
Interferon-beta / therapeutic use
Multiple Sclerosis / drug therapy*
Multiple Sclerosis / immunology
Multiple Sclerosis / physiopathology
Neuroprotective Agents / pharmacology*
Neuroprotective Agents / therapeutic use
Wallerian Degeneration / drug therapy
Wallerian Degeneration / immunology
Wallerian Degeneration / physiopathology

Substances

Immunologic Factors
Neuroprotective Agents
Interferon-beta